Literature DB >> 8537046

Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma.

E M Nilsen1, K E Lundin, P Krajci, H Scott, L M Sollid, P Brandtzaeg.   

Abstract

Coeliac disease is precipitated in susceptible subjects by ingestion of wheat gluten or gluten related prolamins from some other cereals. The disease is strongly associated with certain HLA-DQ heterodimers, for example, DQ2 (DQ alpha 1*0501, beta 1*0201) in most patients and apparently DQ8 (DQ alpha 1*0301, beta 1*0302) in a small subset. Gluten specific T cell clones (TCC) from coeliac intestinal lesions were recently established and found to be mainly restricted by HLA-DQ2 or HLA-DQ8. Antigen induced production of cytokines was studied in 15 TCC from three patients, 10 being DQ2 and five DQ8 restricted. Cell culture supernatants were prepared by stimulation with gluten peptides in the presence of DQ2+ or DQ8+ Epstein-Barr virus transformed B cells as antigen presenting cells (APC). Supernatants were analysed for cytokines by bioassays, ELISA, and CELISA. Cellular cytokine mRNA was analysed semi-quantitatively by slot blotting and polymerase chain reaction (PCR). All TCC were found to secrete interferon (IFN) gamma, often at high concentrations (> 2000 U/ml); some secreted in addition interleukin (IL) 4, IL 5, IL 6, IL 10, tumour necrosis factor (TNF), and transforming growth factor (TGF) beta. The last TCC thus displayed a Th0-like cytokine pattern. However, other TCC produced IFN gamma and TNF but no IL 4, or IL 5, compatible with a Th1-like pattern. In conclusion, most DQ8 restricted TCC seemed to fit with a Th0 profile whereas the DQ2 restricted TCC secreted cytokines more compatible with a Th1 pattern. The TCC supernatants induced upregulation of HLA-DR and secretory component (poly-Ig receptor) in the colonic adenocarcinoma cell line HT-29.E10, most probably reflecting mainly the high IFN gamma concentrations. This cytokine, particularly in combination with TNF alpha, might be involved in several pathological features of the coeliac lesion. The characterised cytokine profiles thus support the notion that mucosal T cells activated in situ by gluten in a DQ restricted fashion play a central part in the pathogenesis of coeliac disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8537046      PMCID: PMC1382937          DOI: 10.1136/gut.37.6.766

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  53 in total

1.  Synergistic effect of IL-4 and IFN-gamma on the expression of polymeric Ig receptor (secretory component) and IgA binding by human epithelial cells.

Authors:  J O Phillips; M P Everson; Z Moldoveanu; C Lue; J Mestecky
Journal:  J Immunol       Date:  1990-09-15       Impact factor: 5.422

2.  Serum interleukin-2-receptor in coeliac disease: response to treatment and gluten challenge.

Authors:  J E Crabtree; R V Heatley; L D Juby; P D Howdle; M S Losowsky
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

Review 3.  Regulation of IgA synthesis and immune response by T cells and interleukins.

Authors:  J R McGhee; J Mestecky; C O Elson; H Kiyono
Journal:  J Clin Immunol       Date:  1989-05       Impact factor: 8.317

4.  A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.

Authors:  T Espevik; J Nissen-Meyer
Journal:  J Immunol Methods       Date:  1986-12-04       Impact factor: 2.303

5.  Reduction in the rate of DNA reassociation by sequence divergence.

Authors:  T I Bonner; D J Brenner; B R Neufeld; R J Britten
Journal:  J Mol Biol       Date:  1973-12-05       Impact factor: 5.469

6.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

7.  Relation between HLA-DR-like antigens and secretory component (SC) in jejunal epithelium of patients with coeliac disease or dermatitis herpetiformis.

Authors:  H Scott; P Brandtzaeg; B G Solheim; E Thorsby
Journal:  Clin Exp Immunol       Date:  1981-05       Impact factor: 4.330

8.  Antibodies to IFN-gamma prevent immunologically mediated intestinal damage in murine graft-versus-host reaction.

Authors:  A M Mowat
Journal:  Immunology       Date:  1989-09       Impact factor: 7.397

9.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.

Authors:  T R Mosmann; H Cherwinski; M W Bond; M A Giedlin; R L Coffman
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

10.  Induction of various HLA class II molecules in a human colonic adenocarcinoma cell line.

Authors:  L M Sollid; G Gaudernack; G Markussen; D Kvale; P Brandtzaeg; E Thorsby
Journal:  Scand J Immunol       Date:  1987-02       Impact factor: 3.487

View more
  102 in total

1.  Local challenge of oral mucosa with gliadin in patients with coeliac disease.

Authors:  H Lähteenoja; M Mäki; M Viander; A Toivanen; S Syrjänen
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

2.  Prostaglandins and the induction of food sensitive enteropathy.

Authors:  A M Mowat
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

3.  Getting to grips with gluten.

Authors:  S N McAdam; L M Sollid
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

4.  Intraepithelial and lamina propria lymphocytes show distinct patterns of apoptosis whereas both populations are active in Fas based cytotoxicity in coeliac disease.

Authors:  A Di Sabatino; R Ciccocioppo; S D'Alò; R Parroni; D Millimaggi; M G Cifone; G R Corazza
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

Review 5.  Dysfunctions of the Iga system: a common link between intestinal and renal diseases.

Authors:  Christina Papista; Laureline Berthelot; Renato C Monteiro
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

Review 6.  Celiac disease.

Authors:  Debbie Williamson; Michael N Marsh
Journal:  Mol Biotechnol       Date:  2002-11       Impact factor: 2.695

Review 7.  Targeted modification of wheat grain protein to reduce the content of celiac causing epitopes.

Authors:  C Osorio; N Wen; R Gemini; R Zemetra; D von Wettstein; S Rustgi
Journal:  Funct Integr Genomics       Date:  2012-06-26       Impact factor: 3.410

Review 8.  Recent advances in the understanding of celiac disease: therapeutic implications for the management of pediatric patients.

Authors:  John H Kwon; Richard J Farrell
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

9.  Selective inhibition of extracellular thioredoxin by asymmetric disulfides.

Authors:  Thomas R DiRaimondo; Nicholas M Plugis; Xi Jin; Chaitan Khosla
Journal:  J Med Chem       Date:  2013-01-31       Impact factor: 7.446

10.  Gliadin increases iNOS gene expression in interferon-gamma-stimulated RAW 264.7 cells through a mechanism involving NF-kappa B.

Authors:  Maria Chiara Maiuri; Daniela De Stefano; Guido Mele; Barbara Iovine; Maria Assunta Bevilacqua; Luigi Greco; Salvatore Auricchio; Rosa Carnuccio
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-07-04       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.